Clearmind Medicine

Treatments for Binge Behavior and Mental Health

Health Tech & Life Sciences
Public on CSE on Jun 2022
Public on NASDAQ on Nov 2022
Public Tel Aviv-Yafo, Israel Founded 2021
Last updated 2026-06-18
Total raised
$16.2M
Last: 2025-11
Stage
Public
Founded
2021
Headcount
5
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

Clearmind Medicine develops treatments for binge behavior and mental health, including alcohol use disorder, binge eating and depression. Clearmind develops MEAI that exerts a euphoric alcohol-like experience and a reduced desire to consume alcoholic beverages with potential to change the lives of millions who struggle to drink in moderation.

Funding history · 2 rounds · $16.2M total

2024-01
2025-11
$560K

Q&A

What is Clearmind Medicine's primary focus?
Clearmind Medicine develops treatments for binge behavior and mental health, including alcohol use disorder, binge eating, and depression.
When was Clearmind Medicine founded?
Clearmind Medicine was founded in January 2021.
What is Clearmind Medicine's current employee count?
Clearmind Medicine has 1-10 employees.
What is the most recent funding round for Clearmind Medicine?
Clearmind Medicine completed a PIPE round in November 2025, raising $560,000.
What is Clearmind Medicine's total amount raised to date?
Clearmind Medicine has raised a total of $16,210,000 USD.
When did Clearmind Medicine go public on NASDAQ?
Clearmind Medicine went public on NASDAQ in November 2022.
What was Clearmind Medicine's largest public offering on NASDAQ?
Clearmind Medicine had a public offering on NASDAQ in November 2022, raising $7,500,000.
Who is the CEO of Clearmind Medicine?
Adi Zuloff-Shani is the CEO of Clearmind Medicine.

Team · 2

Head of Project Management
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcareLaboratories
Business model
B2B

Highlights

1 Patents

Tags

drug-discoverymental-healthpharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)